Jiangsu Bioperfectus Technologies Co., Ltd. (SHA:688399)
China flag China · Delayed Price · Currency is CNY
64.30
-0.37 (-0.57%)
May 6, 2025, 2:45 PM CST

SHA:688399 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2016 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Market Capitalization
3,6653,7273,1985,1428,06011,275
Upgrade
Market Cap Growth
16.52%16.52%-37.80%-36.21%-28.51%232.19%
Upgrade
Enterprise Value
1,9261,9799883,0466,68910,317
Upgrade
Last Close Price
64.6765.7254.5687.71127.76173.21
Upgrade
PE Ratio
---2.816.7613.76
Upgrade
PS Ratio
10.4810.667.930.932.846.48
Upgrade
PB Ratio
1.131.150.941.363.186.77
Upgrade
P/TBV Ratio
1.141.160.951.373.216.88
Upgrade
P/FCF Ratio
44.1244.86-3.1911.8214.07
Upgrade
P/OCF Ratio
25.1125.54-2.628.1812.05
Upgrade
EV/Sales Ratio
5.515.662.450.552.365.93
Upgrade
EV/EBITDA Ratio
---1.354.9811.06
Upgrade
EV/EBIT Ratio
---1.405.1011.33
Upgrade
EV/FCF Ratio
23.1923.82-1.899.8112.88
Upgrade
Debt / Equity Ratio
0.070.070.050.030.070.03
Upgrade
Debt / EBITDA Ratio
---0.050.120.05
Upgrade
Debt / FCF Ratio
2.902.90-0.060.240.06
Upgrade
Asset Turnover
0.090.090.091.320.981.01
Upgrade
Inventory Turnover
1.841.841.549.784.264.30
Upgrade
Quick Ratio
5.595.597.143.692.653.07
Upgrade
Current Ratio
5.825.827.453.982.973.41
Upgrade
Return on Equity (ROE)
-0.06%-0.06%-10.41%57.89%56.81%61.04%
Upgrade
Return on Assets (ROA)
-1.13%-1.13%-5.46%32.37%28.36%33.18%
Upgrade
Return on Capital (ROIC)
-1.22%-1.22%-6.44%41.26%37.11%41.63%
Upgrade
Return on Capital Employed (ROCE)
---54.90%49.60%51.90%
Upgrade
Earnings Yield
-0.05%-0.05%-11.69%35.55%14.80%7.27%
Upgrade
FCF Yield
2.27%2.23%-7.02%31.39%8.46%7.11%
Upgrade
Dividend Yield
----7.83%4.04%
Upgrade
Payout Ratio
---32.31%27.27%21.46%
Upgrade
Buyback Yield / Dilution
-13.88%-13.88%0.06%-0.03%0.02%-29.48%
Upgrade
Total Shareholder Return
-13.88%-13.88%0.06%-0.03%7.85%-25.44%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.